Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

PubMed

Impact1: Supporting Innovation in Pediatric and Maternal Health-5 Years of Outcomes.

PMID : 42106561 ·

E, l, i, s, a, b, e, t, , R, o, s, à, s, , C, a, n, y, e, l, l, e, s, ;, , J, u, l, i, a, n, a, , P, e, r, l, ;, , M, a, r, t, a, , A, r, e, n, a, s, -, J, a, l, ;, , A, n, t, j, e, , K, i, r, s, c, h, n, e, r, ;, , I, g, n, a, c, i, o, , A, n, d, r, é, s, , P, é, r, e, z, , R, o, m, e, r, o, ;, , M, o, h, i, t, , S, i, n, g, h, a, l, a, ;, , M, a, n, i, k, a, n, t, a, m, , G, a, d, d, a, m, ;, , A, n, u, r, a, d, h, a, , D, a, y, a, l, ;, , Y, a, i, r, , J, , B, l, u, m, e, n, f, e, l, d, ;, , J, a, m, e, s, , K, , W, a, l, l, ;, , K, u, n, j, , S, h, e, t, h, ;, , J, a, n, e, n, e, , H, , F, u, e, r, c, h

RevueAnnals of biomedical engineering
Année
PMID42106561

Résumé

Impact1 at the Stanford Mussallem Center for Biodesign was established in 2019 through its core partnership with UCSF as an FDA-funded Pediatric Device Consortium. We hypothesized that providing innovators in pediatric and maternal healthcare with mentorship, connections to experts, and grant funding would promote development, validation, approval, and commercialization of safe and effective health technologies for pediatric and maternal patients, and lead to positive broader impacts, measured a

Source officielle

Voir sur PubMed →

Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.

↑